CIBC Asset Management
IRWD icon

CIBC Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

CIBC Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,054
Closed -$53.4K – 1212
2024
Q4 		$53.4K Buy
+12,054
New +$48.9K ﹤0.01% 1203
2022
Q4 		– Sell
-10,070
Closed -$104K – 1166
2022
Q3 		$104K Hold
10,070
– – ﹤0.01% 1177
2022
Q2 		$116K Buy
+10,070
New +$119K ﹤0.01% 1189

Other funds holding IRWD

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

CIBC Asset Management's IRWD Position: Q1 2025 in Review

CIBC Asset Management sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2025, closing a stake of 12,054 shares — an estimated $53.4K sold.

CIBC Asset Management first reported a position in IRWD in Q2 2022 and held it in 3 quarters. The position peaked at $116K in Q2 2022. 200 funds tracked by Wall St. Rank hold IRWD as of Q1 2025.

  • CIBC Asset Management reported no remaining Ironwood Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • CIBC Asset Management sold 12,054 Ironwood Pharmaceuticals shares in Q1 2025, an estimated $53.4K.
  • CIBC Asset Management first reported a position in Ironwood Pharmaceuticals in Q2 2022 and held it in 3 quarters.
  • CIBC Asset Management's Ironwood Pharmaceuticals position peaked at $116K in Q2 2022.
  • 200 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2025.

Based on CIBC Asset Management's 13F filing for Q1 2025, filed 13 May 2025.